![]() Healthcare Training Institute - Quality Education since 1979 CE for Psychologist, Social Worker, Counselor, & MFT!!
Section 3 Question 3 | Test | Table of Contents U.S. Department of Health & Human Services If you wish to increase the text size of this publication, maximize your window. - Giroir, B., Dowell, D., MD, MPH, Jones, C., PharmD, DrPH, Compton, W., MD, MPE, Kato, E., MD, MRP, Dubenitz, J., PhD, Ling, S., MD, Foster, D., DO, MS, MPH, Hertz, S., MD, Sokolowska, M., PhD, Steinberg, J., MD, MPH, Vythilingam, M., MD, and Clarke, T., PhD. (October 2019). HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. U.S. Department of Health and Human Services, 1-6. Update - Kim, E. J., Hwang, E. J., Yoo, Y. M., & Kim, K. H. (2022). Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now. The Korean journal of pain, 35(4), 361–382. https://doi.org/10.3344/kjp.2022.35.4.361
Hall, N. Y., Le, L., Majmudar, I., & Mihalopoulos, C. (2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence, 221, Article 108651. Scott, K., Murphy, C. M., Yap, K., Moul, S., Hurley, L., & Becker, S. J. (2021). Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Translational Issues in Psychological Science, 7(2), 166–176. QUESTION 3 |